Company Update

Remedium Lifecare has reported robust financial results for the quarter ended June 30, 2025. The company achieved a Profit After Tax (PAT) of ₹4.65 Cr, a significant turnaround from a ₹2.05 Cr loss in the previous quarter.

Notably, this Q1 PAT already surpasses and doubles the entire FY25 profit of ₹2.13 Cr.

Revenue from operations stood at ₹113.37 Cr.

This strong performance highlights improved operational efficiency and strategic execution.

The company plans long-term growth by expanding R&D, developing CDMO services for improved margins, enhancing working capital, and pursuing global market expansion, aiming for sustained growth and shareholder value.